Abstract
Sheng-Mai-San (SMS), a traditional Chinese formulation used for the treatment of coronary heart disease, is comprised of Radix Ginseng, Fructus Schisandrae and Radix Ophiopogonis. Pretreatment with a lignan-enriched SMS (17 g/kg/day x 3, p.o.) was found effective in protection against isoproterenol-induced myocardial injury in rats, and in ischemia-reperfusion injury in isolated perfused hearts prepared from pretreated animals. Results obtained from pretreatment studies using extracts prepared by mixing various combinations of the three component herbs indicate that the major myocardial protective component in SMS is the lignan-enriched extract of Fructus Schisandrae.
Citations
Sep 15, 2006·Urological Research·Mayur Danny I Gohel, Siu Ping Wong
Jun 6, 2007·Evidence-based Complementary and Alternative Medicine : ECAM·Lei WangTetsuya Konishi
Sep 22, 2005·Clinical and Experimental Pharmacology & Physiology·I Y LeeM T Lin
Aug 31, 2001·The American Journal of Chinese Medicine·N WangH Fujiwara
Jul 5, 2003·Biological & Pharmaceutical Bulletin·Lei WangTetsuya Konishi
Jul 1, 2014·Fitoterapia·Jung Nyeo ChunJu-Hong Jeon
Nov 6, 2008·Journal of Ethnopharmacology·Ji Young ParkChi Dae Kim
Nov 1, 2003·The American Journal of Chinese Medicine·Haruyo IchikawaTetsuya Konishi
Mar 23, 2006·The American Journal of Chinese Medicine·Jyh-Sheng YouYing-Shiung Lee
Jun 3, 2008·Journal of Ethnopharmacology·Alexander Panossian, Georg Wikman
Jun 26, 2018·Canadian Journal of Physiology and Pharmacology·Xiaohong Tracey Gan, Morris Karmazyn
Apr 30, 2016·The Cochrane Database of Systematic Reviews·Jie ChenJin Chen
May 10, 2019·Pharmaceutical Biology·Xiu ChenZhiyong Yan
Apr 6, 2019·Frontiers in Pharmacology·Siyao HuBoyang Yu